Observational - Registry
The Registry of persons with kidney disease Considering participation in Research Database (RECORD) stems from Canadians Seeking Solutions and Innovations for Chronic Kidney Disease (Can SOLVE CKD). Patient and knowledge user engagement in Can SOLVE CKD suggested patients are interested in participating in clinical research but are often unaware of opportunities. Similarly, nephrology researchers are uncertain of the potential numbers and logistics of approaching patients in many centres across Canada to participate in clinical research. A registry that actively informs patients of the reasons for research and potential research opportunities that they could participate in may help foster a culture of participation for both patients and researchers. Additionally, this registry would inform researchers about the number and location of potential participants at Canadian centres.
RECORD will register patients undergoing treatment for kidney disease in Canada who are interested in potentially participating in clinical research and collect information about the type of research they are willing to participate in both generally (i.e., observational, requiring blood, urine or genetic samples, interventional with an older/ already in-use pharmacologic agent, interventional with a new pharmacologic agent, interventional with a medical device, interventional with a change in dialysis, interventional with a behavioral intervention), and will also collect information about the relevance, acceptability and eligibility of clinical research studies that are planned. Finally, RECORD will allow participants to receive information about what clinical kidney research is occurring in Canada and whether there are specific opportunities that are relevant to them.Download Presentation PDF
Observational - Registry
Michael Walsh is a Principal Investigator in the Renal research program at PHRI, and an Assistant Professor, Department of Medicine (nephrology), McMaster University. His research activities are in the areas of the treatment of patients who require dialysis, severe glomerular disease, and perioperative acute kidney injury. He has published more than 70 papers and two book chapters.
He holds a Kidney Research Scientist Core Education and National Training (KRESCENT) Program New Investigator award through CIHR and the Kidney Foundation of Canada. He’s received multiple Top Abstract awards from the Canadian Society of Nephrology, the Chalmers Prize from the Society for Clinical Trials, and the Detweiller Traveling Scholar Award from the College of Physicians and Surgeons of Canada.
Tara McCready, PhD, oversees a variety of collaborative programs at PHRI, and serves as Project Manager for PHRI research studies and registries.
She was recruited to PHRI as a Program Director for the Canadian Network and Centre for Trials Internationally (CANNeCTIN), a national network funded by the CIHR/CFI Clinical Research Initiative program to improve the prevention and treatment of cardiac and vascular diseases and diabetes.
Previously the Executive Director of the Canadian Maternal, Infant, Child and Youth Research Network, Tara holds a PhD in Biochemistry and a MBA in Technology Commercialization from the University of Alberta.
Back To Top